Anonymous blog comment suggests lack of confidentiality in peer review — and plays role in a new paper

A new paper in Intelligence is offering some, well, intel into the peer review process at one prestigious neuroscience journal. The new paper is about another paper, a December 2012 study, “Fractionating Human Intelligence,” published in Neuron by Adam Hampshire and colleagues in December 2012. The Neuron study has been cited 16 times, according to Thomson … Continue reading Anonymous blog comment suggests lack of confidentiality in peer review — and plays role in a new paper

Harvard-Brigham heart researcher under investigation earns Lancet Expression of Concern

On Tuesday, we broke the news of the retraction in Circulation of a paper on cardiac stem cells by a group of researchers being investigated by Harvard Medical School and the Brigham and Women’s Hospital. Today, The Lancet has issued an Expression of Concern about another paper led by Piero Anversa, the last author of … Continue reading Harvard-Brigham heart researcher under investigation earns Lancet Expression of Concern

Waseda University checking dissertations for plagiarism in wake of STAP stem cell misconduct finding

Waseda University in Japan says it will be vetting every doctoral dissertation it awards its graduate-level students in Advanced Science & Engineering* for signs of plagiarism, according to a report in the Japan News, a site of the Yomiuri Shimbun. The paper reports that:

Does publicly questioning papers lead to more corrections and retractions?

As Retraction Watch readers will likely recall, Paul Brookes ran Science-Fraud.org anonymously until early 2013, when he was outed and faced legal threats that forced him to shut down the site. There are a lot of lessons to be drawn from the experience, some of which Brookes discussed with Science last month. Today, PeerJ published Brookes’ … Continue reading Does publicly questioning papers lead to more corrections and retractions?

Novartis Diovan scandal claims two more papers

A complicated story involving Novartis’s valsartan (Diovan) has led to the retraction of two more papers, one cascading from the other. Last September, The Lancet retracted the Jikei Heart Study after a slew of retractions of related work prompted an investigation of valsartan research. That investigation found evidence of data manipulation and the failure of … Continue reading Novartis Diovan scandal claims two more papers

RIKEN finds two “instances of research misconduct” in STAP stem cell work

Japan’s RIKEN research center has found misconduct in work that led to two controversial Nature papers, purporting to show an easy way to create stem cells, that have been dogged by criticism for months. Here’s an excerpt from today’s statement about “six items [RIKEN] has been investigating:”